Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450047
Status:
COMPLETED
Last Update Posted:
2007-03-21
First Post:
2007-03-20
Brief Title:
Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia
Sponsor:
Hiroshima University
Organization:
Hiroshima University
Study Overview
Official Title:
Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to verify the efficacy of speed-feedback therapy in improving the cognitive function of elderly people with dementia by a randomized controlled trial and to demonstrate how that affects ADL and QOL
Detailed Description:
Dementia is a syndrome caused by diseases of the cerebral parenchyma and it is a state in which cognitive functions including attention memory thinking comprehension judgment and computation are diminished Because of the mental symptoms problem behaviors and decreased activities of daily living ADL it is also recognized as a major social problem However rehabilitation of elderly people with dementia is still at the trial-and-error stage and establishing a method of rehabilitation is an urgent task In 2004 the authors devised and created a training method that integrates exercise therapy with feedback therapy to treat the cognitive dysfunction of elderly people with dementia To do so the authors introduced speed-feedback therapy with a bicycle ergometer as a feedback therapy intervention The results of a preliminary study of the efficacy of this method in improving cognitive dysfunction in 17 elderly persons with dementia showed improvement in cognitive dysfunction and their attentiveness also improved suggesting that the impaired attentiveness may have improved in response to treatment by this method and as a result have led to improvement of cognitive dysfunction However it became clear that it would be necessary to further improve and develop the system and to demonstrate its efficacy in a controlled trial and verify associations between improvement of cognitive dysfunction and improvement of the ADL of dementia patients and their quality of life QOL
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None